Detalhe da pesquisa
1.
Docking Protein p130Cas Regulates Acinar to Ductal Metaplasia During Pancreatic Adenocarcinoma Development and Pancreatitis.
Gastroenterology
; 162(4): 1242-1255.e11, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34922945
2.
Conditional ablation of p130Cas/BCAR1 adaptor protein impairs epidermal homeostasis by altering cell adhesion and differentiation.
Cell Commun Signal
; 16(1): 73, 2018 11 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30390666
3.
Correction to: Conditional ablation of p130Cas/BCAR1 adaptor protein impairs epidermal homeostasis by altering cell adhesion and differentiation.
Cell Commun Signal
; 16(1): 90, 2018 11 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-30477510
4.
Assessing tumor vascularization as a potential biomarker of imatinib resistance in gastrointestinal stromal tumors by dynamic contrast-enhanced magnetic resonance imaging.
Gastric Cancer
; 20(4): 629-639, 2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-27995483
5.
Nuclear Akt2 opposes limbal keratinocyte stem cell self-renewal by repressing a FOXO-mTORC1 signaling pathway.
Stem Cells
; 32(3): 754-69, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24123662
6.
Morgana acts as a proto-oncogene through inhibition of a ROCK-PTEN pathway.
J Pathol
; 234(2): 152-63, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24615293
7.
Cas proteins: dodgy scaffolding in breast cancer.
Breast Cancer Res
; 16(5): 443, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25606587
8.
p130Cas alters the differentiation potential of mammary luminal progenitors by deregulating c-Kit activity.
Stem Cells
; 31(7): 1422-33, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23592522
9.
p130Cas/Cyclooxygenase-2 axis in the control of mesenchymal plasticity of breast cancer cells.
Breast Cancer Res
; 14(5): R137, 2012 Oct 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-23098208
10.
p130Cas: a versatile scaffold in signaling networks.
Trends Cell Biol
; 16(5): 257-63, 2006 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-16581250
11.
p130Cas is an essential transducer element in ErbB2 transformation.
FASEB J
; 24(10): 3796-808, 2010 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-20505116
12.
p130Cas/BCAR1 and p140Cap/SRCIN1 Adaptors: The Yin Yang in Breast Cancer?
Front Cell Dev Biol
; 9: 729093, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34708040
13.
Interfering with inflammation: a new strategy to block breast cancer self-renewal and progression?
Breast Cancer Res
; 12(2): 305, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20459595
14.
Integrins and signal transduction.
Adv Exp Med Biol
; 674: 43-54, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20549939
15.
The SRCIN1/p140Cap adaptor protein negatively regulates the aggressiveness of neuroblastoma.
Cell Death Differ
; 27(2): 790-807, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31285546
16.
Correction to: The SRCIN1/p140Cap adaptor protein negatively regulates the aggressiveness of neuroblastoma.
Cell Death Differ
; 27(4): 1448, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-31488891
17.
Convergence of integrins and EGF receptor signaling via PI3K/Akt/FoxO pathway in early gene Egr-1 expression.
J Cell Physiol
; 218(2): 294-303, 2009 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-18844239
18.
Author Correction: Modeling ErbB2-p130Cas interaction to design new potential anticancer agents.
Sci Rep
; 9(1): 17729, 2019 Nov 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-31758081
19.
Modeling ErbB2-p130Cas interaction to design new potential anticancer agents.
Sci Rep
; 9(1): 3089, 2019 02 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-30816273
20.
p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.
Cancer Res
; 66(9): 4672-80, 2006 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16651418